# Mirum Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Jan 27, 2026

- Company: [Mirum Pharmaceuticals, Inc.](/companies/mirm.md) (CIK 1759425)
- Form: SCHEDULE 13D/A
- Filed: 2026-01-27
- Accepted by EDGAR: Jan 27, 2026, 16:12 ET
- Period: not reported
- Accession: 0001231919-26-000093
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1759425/000123191926000093/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1759425/000123191926000093/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1759425/000123191926000093/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001231919-26-000093. Last ingested by Listed: Nov 14, 2026, 22:38 ET. No prices; not investment advice.
